Current Medicinal Chemistry

Editor-in-Chief

Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge
Cambridge
(UK)

Nobel Laureates on Editorial Board

Prof. John Gurdon
(UK)

Prof. Jean-Marie Lehn
(France)

Prof. Ferid Murad
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 19 Issue: 8, March

Editorial [Hot Topic: Recent Achievements on G-Protein Coupled Receptors (Guest Editor: Slawomir Filipek)]

Volume:19   Issue: 8
Pp: 1089-1089
Slawomir Filipek
DOI: 10.2174/092986712799320501
Published on: 01 March, 2012

Action of Molecular Switches in GPCRs - Theoretical and Experimental Studies open access plus

Volume:19   Issue: 8
Pp: 1090-1109
B. Trzaskowski, D. Latek, S. Yuan, U. Ghoshdastider, A. Debinski and S. Filipek
DOI: 10.2174/092986712799320556
Published on: 01 March, 2012

Evolution of Class A G-Protein-Coupled Receptors: Implications for Molecular Modeling

Volume:19   Issue: 8
Pp: 1110-1118
M. Chabbert, H. Castel, J. Pele, J. Deville, R. Legendre and P. Rodien
DOI: 10.2174/092986712799320600
Published on: 01 March, 2012

Crosstalk within GPCR Heteromers in Schizophrenia and Parkinsons Disease: Physical or Just Functional?

Volume:19   Issue: 8
Pp: 1119-1134
R. Guixa-Gonzalez, A. Bruno, M. Marti-Solano and J. Selent
DOI: 10.2174/092986712799320574
Published on: 01 March, 2012

A Closer Look into G Protein Coupled Receptor Activation: X-Ray Crystallography and Long-Scale Molecular Dynamics Simulations

Volume:19   Issue: 8
Pp: 1135-1145
S. Vanni and U. Rothlisberger
DOI: 10.2174/092986712799320493
Published on: 01 March, 2012

Ensemble of G Protein-Coupled Receptor Active States

Volume:19   Issue: 8
Pp: 1146-1154
P. S.-H. Park
DOI: 10.2174/092986712799320619
Published on: 01 March, 2012

Recent Progress in Understanding of Structure, Ligand Interactions and the Mechanism of Activation of the β 2-Adrenergic Receptor

Volume:19   Issue: 8
Pp: 1155-1163
M. Kolinski, A. Plazinska and K. Jozwiak
DOI: 10.2174/092986712799320547
Published on: 01 March, 2012

RAS/RAF/MEK Inhibitors in Oncology open access plus

Volume:19   Issue: 8
Pp: 1164-1176
M. Broggini
DOI: 10.2174/092986712799320510
Published on: 01 March, 2012

Diketoacid Inhibitors of HIV-1 Integrase: From L-708,906 to Raltegravir and Beyond

Volume:19   Issue: 8
Pp: 1177-1192
K. D. Beare, M. J. Coster and P. J. Rutledge
DOI: 10.2174/092986712799320565
Published on: 01 March, 2012

Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches

Volume:19   Issue: 8
Pp: 1193-1209
G. Siasos, D. Tousoulis, C. Kollia, E. Oikonomou, Z. Siasou, C. Stefanadis and A. G. Papavassiliou
DOI: 10.2174/092986712799320583
Published on: 01 March, 2012

New Developments in the Diagnosis and Management of Resistant Hypertension

Volume:19   Issue: 8
Pp: 1210-1218
A. de la Sierra
DOI: 10.2174/092986712799320592
Published on: 01 March, 2012

Advances in the Research of β-Ketoacyl-ACP Synthase III (FabH) Inhibitors

Volume:19   Issue: 8
Pp: 1225-1237
H. -J. Zhang, Z. -L. Li and H. -L. Zhu
DOI: 10.2174/092986712799320484
Published on: 01 March, 2012

Targeting DNA Topoisomerase I with Non-Camptothecin Poisons

Volume:19   Issue: 8
Pp: 1238-1257
G. L. Beretta, V. Zuco, P. Perego and N. Zaffaroni
DOI: 10.2174/092986712799320529
Published on: 01 March, 2012